Novel targeted drugs for the treatment of multiple myeloma: from bench to bedside

被引：46
|
作者：
Bruno, B
Giaccone, L
Rotta, M
Anderson, K
Boccadoro, M
机构：
[1] Univ Turin, Div Ematol, Osped S Giovanni Battist, I-10126 Turin, Italy
[2] Dana Farber Canc Inst, Jerome Lipper Multiple Myeloma Ctr, Boston, MA 02115 USA
来源：
LEUKEMIA | 2005年 / 19卷 / 10期
关键词：
mutliple myeloma; new drugs; signaling pathways;
D O I：
10.1038/sj.leu.2403905
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Multiple myeloma remains an incurable plasma cell neoplasm. New insights into its pathogenesis have identified signaling pathways that have become potential therapeutic targets. It has clearly been established that intracellular regulatory proteins and interactions between malignant plasma cells and the bone marrow microenvironment play an important role in their survival and drug resistance. Several new agents associated with molecular targets are currently being investigated to design new treatment strategies aimed at prolonging survival and improving quality of life. This review illustrates their mechanisms of action and the possible future clinical applications.
引用
收藏
页码：1729 / 1738
页数：10
相关论文
共 50 条
  • [31] Development of Targeted Alpha Therapy from Bench to Bedside
    Morgenstern, Alfred
    Bruchertseifer, Frank
    JOURNAL OF MEDICAL IMAGING AND RADIATION SCIENCES, 2019, 50 (04) : S18 - S20
  • [32] The 39th David A. Karnofsky Lecture: Bench-to-Bedside Translation of Targeted Therapies in Multiple Myeloma
    Anderson, Kenneth C.
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (04) : 445 - 452
  • [33] From Bench to Bedside The Evolution of Genomics and Its Implications for the Current and Future Management of Multiple Myeloma
    Morgan, Gareth J.
    Boyle, Eileen M.
    Davies, Faith E.
    CANCER JOURNAL, 2021, 27 (03): : 213 - 221
  • [34] Pediatric multiple sclerosis - from bench to bedside
    Ciampi, Ethel
    Palavra, Filipe
    FRONTIERS IN NEUROSCIENCE, 2024, 18
  • [35] Cytokines in multiple sclerosis: from bench to bedside
    Imitola, J
    Chitnis, T
    Khoury, SJ
    PHARMACOLOGY & THERAPEUTICS, 2005, 106 (02) : 163 - 177
  • [36] Nitric oxide releasing drugs: from bench to bedside
    Cirino, G
    DIGESTIVE AND LIVER DISEASE, 2003, 35 : S2 - S8
  • [37] Anorectic drugs and pulmonary hypertension from the bedside to the bench
    Mchelakis, ED
    Weir, EK
    AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 2001, 321 (04): : 292 - 299
  • [38] Study Tests Targeted Drugs for Multiple Myeloma
    Caruso, Catherine
    CANCER DISCOVERY, 2019, 9 (04) : 459 - 459
  • [39] The novel antioxidant edaravone: From bench to bedside
    Watanabe, Toshiaki
    Tahara, Munenori
    Todo, Satoru
    CARDIOVASCULAR THERAPEUTICS, 2008, 26 (02) : 101 - 114
  • [40] Endoxifen, an Estrogen Receptor Targeted Therapy: From Bench to Bedside
    Jayaraman, Swaathi
    Reid, Joel M.
    Hawse, John R.
    Goetz, Matthew P.
    ENDOCRINOLOGY, 2021, 162 (12)
12345